CHRFAM7A reduces monocyte/macrophage migration and colony formation in vitro.


Journal

Inflammation research : official journal of the European Histamine Research Society ... [et al.]
ISSN: 1420-908X
Titre abrégé: Inflamm Res
Pays: Switzerland
ID NLM: 9508160

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 02 04 2020
accepted: 10 04 2020
revised: 08 04 2020
pubmed: 19 4 2020
medline: 7 10 2020
entrez: 19 4 2020
Statut: ppublish

Résumé

CHRFAM7A is a unique human gene that encodes a dominant negative inhibitor of the α7 nicotinic acetylcholine receptor. We have recently shown that CHRFAM7A is expressed in human leukocytes, increases cel-cell adhesion, and regulates the expression of genes associated with leukocyte migration. Human THP-1, RAW264.7 and HEK293 cells. Cell migration, cell proliferation and colony formation in soft agar to compare the biological activity of vector vs. CHRFAM7A-transduced cells. We show that gene delivery of CHRFAM7A into the THP-1 human monocytic cell line reduces cell migration, reduces chemotaxis to monocyte chemoattractant protein, and reduces colony formation in soft agar. Taken together, the findings demonstrate that CHRFAM7A regulates the biological activity of monocytes/macrophages to migrate and undergo anchorage-independent growth in vitro.

Identifiants

pubmed: 32303780
doi: 10.1007/s00011-020-01349-7
pii: 10.1007/s00011-020-01349-7
pmc: PMC7263946
mid: NIHMS1585796
doi:

Substances chimiques

Chrna7 protein, human 0
alpha7 Nicotinic Acetylcholine Receptor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

631-633

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM121530
Pays : United States
Organisme : NIDCD NIH HHS
ID : 5T32DC000028-27
Pays : United States
Organisme : NIGMS NIH HHS
ID : 5R01GM121530-03
Pays : United States

Références

Mol Med. 2015 Apr 03;21:323-36
pubmed: 25860877
J Cell Biochem. 2016 Jul;117(7):1511-21
pubmed: 26442636
J Leukoc Biol. 2015 Feb;97(2):247-57
pubmed: 25473097
Nature. 2002 Dec 19-26;420(6917):853-9
pubmed: 12490958
Matrix Biol. 2014 Apr;35:152-61
pubmed: 24513039
Mol Cell Biol. 2008 Nov;28(22):6889-902
pubmed: 18794361
J Biol Chem. 2003 Sep 5;278(36):34411-7
pubmed: 12821669
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7932-7940
pubmed: 30944217

Auteurs

Theresa W Chan (TW)

Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery, Department of Surgery, University of California San Diego School of Medicine, 200 W. Arbor Drive #8896, San Diego, CA, 92103, USA.

Simone Langness (S)

Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery, Department of Surgery, University of California San Diego School of Medicine, 200 W. Arbor Drive #8896, San Diego, CA, 92103, USA.

Olga Cohen (O)

Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery, Department of Surgery, University of California San Diego School of Medicine, 200 W. Arbor Drive #8896, San Diego, CA, 92103, USA.

Brian P Eliceiri (BP)

Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery, Department of Surgery, University of California San Diego School of Medicine, 200 W. Arbor Drive #8896, San Diego, CA, 92103, USA.

Andrew Baird (A)

Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery, Department of Surgery, University of California San Diego School of Medicine, 200 W. Arbor Drive #8896, San Diego, CA, 92103, USA.

Todd W Costantini (TW)

Division of Trauma, Surgical Critical Care, Burns and Acute Care Surgery, Department of Surgery, University of California San Diego School of Medicine, 200 W. Arbor Drive #8896, San Diego, CA, 92103, USA. tcostantini@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH